Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of nonsteroidal anti-inflammatory drugs (NSAIDs). Its structure supports the inhibition of cyclooxygenase (COX) enzymes, contributing to anti-inflammatory, analgesic, and antipyretic effects. Additionally, it is utilized in research and development of hypoglycemic agents and antimicrobial drugs. The sulfonamido group enhances its ability to bind with biological targets, offering high potential for further medical and pharmaceutical applications due to favorable solubility and binding characteristics.